day 1 agenda

4th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA 
Sep 13 - 14, 2023 at Barcelona, Spain
SCIENTIFIC PROGRAM
Day 1 - September 13, 2023
Hall -Sitges
07:45-08:45 Registrations Open
08:45-09:00 Welcome remarks by Moderator
   
Keynote Talks
09.00-09.30 Title:  Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid (beta)
Martin Bachmann, University of Bern,Switzerland
   
09:30-10:00 Title: House as Carer: enabling older adults with Dementia to live at Home
Masi Mohammadi, Eindhoven University of Technology, The Netherlands 
   
10.00-10.30 Title:  The Italian INTERCEPTOR project
Paolo M. Rossini, Catholic University in Rome, Itlay
   
10:30-10:50 Group Photo & Refreshment Break @ Foyer
   
Alzheimer's Research and Therapy
       &
Advances in Alzheimer’s and Dementia Research
   
Session Chairs:  Dr. Paolo M. Rossini & Dr. Gerard Griffioen
   
10-50-11:10 Title: Intranasal Dantrolene Nanoparticle As A Disease-Modifying Drug For Treatment of Alzheimer’s Disease
Huafeng Wei, University of Pennsylvania, USA
   
11:10-11:30 Title: Non-Invasive Neurostimulation in Home Settings for Cognitive Enhancement in Mild to Moderate Alzheimer’s Disease
Helena Knotkova, MJHS Institute for Innovation in Palliative Care,USA
   
11:30-11:50 Title: Neuromodulation for word finding in logopenic primary progressive aphasia secondary to Alzheimer’s disease: A subphonemic analysis
Tifani Biro, University of Pennsylvania,USA
   
11:50-12:10 Title: Organ on a chip in vitro model in Alzheimer disease
Monica Mir, University of Barcelona,Spain
   
12:10-12:30 Title: GHS-R1a deficiency rescues memory decline in AD model mice
YU ZHOU, University of Health and Rehabilitation Sciences,China
   
12:30-12:50 Title: Life span changes in the CD4 T-cell compartment and their impact on aging and disease
Alon Monsonego, Ben-Gurion University, Israel.
   
12:50-14:00 Lunch Break @ Restaurant
Session Chairs:
Prof .Jacques P. Tremblay & Prof. Maria Carla Tesi
14:00-14:20 Title: Neuroprotective Features of angiotensin receptor blockers in Preclinical Alzheimer’s mouse models
Lusine Danielyan, University Hospital of Tuebingen, Tuebingen, Germany
   
14:20-14:40 Title: The synergistic interplay between amyloid beta and tau in Alzheimer’s disease: a mathematical model on the human connectome
Maria Carla Tesi, University of Bologna,Itlay
   
14:40-15:00 Title: AUTOTAC (AUTOphagy-TArgeting Chimera): Targeted degradation of tau tangles in Alzheimer’s disease via the autophagy-lysosome system
Yong Tae Kwon, Seoul National University, Seoul, Korea
   
15:00-15:20 Title: Neuroprotection in Alzheimer’s disease by restoring intraneuronal calcium homeostasis
Gerard Griffioen,reMYND N.V, Belgium
   
15:20-15:40 Title:National Institute on Aging Seed Funding enables Alzheimer’s disease startups to reach key value inflection points
Armineh L Ghazarian, National Institute on Aging,USA
   
15:40-16:00 Title: Insertion of the Icelandic mutation (A673T) in the APP gene using the CRISPR/Cas9 base editing and Prime editing technologies, a preventive treatment for Alzheimer?
Jacques P. Tremblay, Laval University, Canada
   
16:00-16:20 Refreshment Break @ Foyer
   
   
16:20-16:40 Title:A Psychiatric Perspective on the Neuropsychiatric Symptoms in Dementia 
Arushi Kapoor, University of Pennsylvania, USA
   
16:40-17:00 Title: Frontotemporal brain sagging syndrome
Luis Alberto Ortega-Porcayoa, HOSPITAL ANGELES PEDREGAL,Mexico
   
17:00-17:20 Title: Consensus recommendations on Epilepsy in Phelan-McDermid syndrome 
Sarah Jesse, ULM University, Germany
   
Day 1 Concludes

day 2 agenda

4th Edition of Innovations and State of the Art in
ALZHEIMER'S & DEMENTIA 
Day-2 (September 14, 2023)
Hall- Sitges
Moderator: Memoona Hasnain, USA
Keynote Talk
09:00-09:30 Title: Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
David St Clair, University of Aberdeen, UK
Technical session-II
   
Vascular Dementia, Aging and Dementia
       &
Molecular and Cell Biology, Risk reduction and prevention
   
Session Chairs:
Dr. Masi Mohammadi & Dr. Zixu Mao
   
09:30-9:50 Title: White matter mechanisms in a spontaneous mouse model of chronic mild hypoperfusion with eNOS deficiency
Francesca-Fang Liao, University of Tennessee Health Science Center,USA
   
09:50-10:10 Title:Nutrition and Memory Brain Health
Gunjan Khera,United Arab Emirates University, UAE
   
10:10-10:30 Title: Age of onset influences stigmatic attributions towards a person with dementia
Lilach Raviv Turgeman, Zefat Academic College, Zefat, Israel
   
10:30- 10:50 Refreshment Break @ Foyer
   
10:50-11:10 Title: Screening of pathogenic variants in eight Alzheimer’s disease related genes in Bulgarian patients by pooled whole-exome sequencing
Sena Karachanak-Yankova,Medical University of Sofia, Sofia, Bulgaria
   
11:10-11:30 Title:Study the Therapeutic Benefit of Commercial Coffees for AD in N2a/APPswe Cell Model
Chuanhai Cao,University of South Florida, USA
   
11:30-11:50 Title: Dysfunction of miRNA biogenic machinery in neuronal stress and Alzheimer’s disease
Zixu Mao, Emory University School of Medicine, USA
   
11:50-12:10 Title: Concerted role of CX3CL1 and proteases in Alzheimer’s disease “in vitro” and “in vivo”
Giulio Ghersi & Matilda Iemmolo,University of Palermo, Palermo, Italy 
   
12:10-12:30 Title: Intermittent Fasting as a Potential Preventative Treatment for the Progression from Type II to Type III Diabetes (Alzheimer's Disease)
Joseph M. Schulz , University of Miami , USA
   
12:30-12:50 Title:Economics of the community mechanism: applications to communities in which some members have dementia
Masao Ogaki, Keio University, Japan
   
12:50-14:00 Lunch Break @ Restaurant
Technical session-III
Dementia care research and Practice,
       Dementia diagnosis, treatment & Living with Alzheimer’s & Dementia: The Experiences
   
Session Chairs
 Dr.Erwin L. Roggen & Dr. Valerie Gruss
   
14:00-14:20 Title: Search for miRNAs implicated in a putative Adverse Outcome Pathway (AOP) with the potential to predict sporadic Alzheimer’s disease inn the preclinical phase.
Erwin L. Roggen, ToxGenSolutions, Maastricht, Netherlands
   
14:20-14:40 Title: The results of dementia community care implementation in rural area of Eastern Taiwan
Wenting Tseng, Mennonite Hospital Shou_feng Branch, Hualien County, Taiwan
   
14:40-15:00 Title:The future of aging: Utilizing mobile technology to educate the public about Alzheimer’s Disease
Valerie Gruss & Memoona Hasnain, University of Illinois at Chicago,USA
   
Poster Presentation
   
15:00-15:15 Title: Neurocognitive dysfunction among type 2 diabetes patients attending primary health care in Jeddah, Saudi Arabia
Alshaymaa A. Alshaikh, NGH, Saudi Arabia
15:15-15:30 Refreshment Break @ Foyer
  Conference Ends

posters agenda

posters will be updated soon.

posters agenda

4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA(Virtually through Zoom)
Sep 13, 2023 (CEST -Barcelona Time)
11:00-11:20 Title: Sleep, physical activity, sedentary behavior, and risk of incident dementia: a prospective cohort study of 431,924 UK Biobank participants
Shuyi Huang, Fudan University, China
11:20-11:40 Title: The effect of perceived threat avoidability of COVID-19 on coping strategies and psychic anxiety among Chinese college students in the early stage of COVID-19 pandemic
Wenpei Zhang, Anhui University of Technology, China
11:40-12:00 Title:Vietnamese Version of Cornell Scale for Depression in Dementia at an Outpatient Memory Clinic: A Reliability and Validity Study
Tan Thanh Huynh,Pham Ngoc Thach University of Medicine, Vietnam
12:00-12:30 Keynote: Microbiota changes associated with Alzheimer’s disease risk factors: indicators for protective treatments
Illana Gozes,Tel Aviv University, Israel
12:30-12:50 Title: Neutralization of Interleukin-17 (IL-17) ameliorates systemic inflammation and peripheral vascular dysfunction associated to Alzheimer’s disease
Valentina Vellecco, University of Naples Federico II, Italy
12:50-13:10 Title: A new prototype of an antiepileptic drug acts mainly at the posttranslational level on a model of maximum electroshock in mice
Artem I.Davletshin, Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, Russia
13:10-13:40 Keynote: Neurophysiological Approach by Self-Control of your Stressrelated Autonomic Nervous System 
Kees Blase, National Centre Stress management, Netherlands
13:40-14:10 Keynote: Is Alzheimer’s disease a disease? 
Amos D Korczyn, Tel Aviv University, Israel
14:10-14:30 Title: Alzheimer’s Disease: Beyond Neuroinflammation and Immunosenescence
Stephan Chee, NHS, UK
14:30-14:50 Title: How Special care units could support narrativity?
Valentin INSARDI, University of Strasbourg, France
14:50-15:10 Title: Association Between Cognitive Impairment and Motor Dysfunction in Patients with Multiple Sclerosis: A Cross-sectional Study
Hanadi Matar Alharthi, King Saud University Medical City, Saudi Arabia
15:10-15:30 Title: Barriers and facilitators to adherence to exercise groups amongst the population of older people living with dementia in the community
Rosaria Gracia, The Open university, UK
15:30-15:50 Title: Sympathetic Hyperactivity and its Degenerative Consequences in Stem Cell and Mouse Models of Familial Dysautonomia
Nadja Zeltner,University of Georgia, USA
15:50-16:10 Title: Down syndrome and dementia: cognitive measurement and monitoring
Jordan Harp,University of Kentucky College of Medicine, USA
16:10-16:30 Title: Super-resolution neural network-driven mouse cerebrovascular mapping with MION-based MRI
Xiaoqing Alice Zhou, Harvard Medical School, USA
16:30-16:50 Title: A peptide blocking the ADORA1-neurabin interaction is anticonvulsant and inhibits epilepsy in an Alzheimer’s model
Qin Wang,Medical College of Georgia at Augusta University, USA
16:50-17:10 Title: A novel strategy for Alzheimer’s disease treatment using blood/plasma exchange
Claudio Soto, University of Texas Health Science Center at Houston, USA
17:10-17:30 Title: Utilizing Timed Categorical Recall (naming U. S. cities) for Rapid Bedside Dementia Screening
Charles R. Joseph, Liberty University College of Osteopathic Medicine, USA
17:30-17:50 Title: Clinical Development of a Novel Synaptogenic Molecule to treat Alzheimer’s and other Neurodegenerative Diseases
Vincent F. Simmon, Spinogenix, Inc.USA
17:50-18:10 Title: APOE genotype mediates differential alterations in HDL particle size distribution and function in patients with Alzheimer’s and mild cognitive impairment vs. controls
Angela M. Zivkovic, University of California, USA
18:10-18:30 Title: Interferon-induced protein in HIV-1 Associated Neurocognitive Disorders (HAND) and Alzheimer's Disease Pathology
Upal Roy, The University of Texas Rio Grande Valley, USA
Day-1 Concludes
   
4th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA(Virtually through Zoom)
Sep 14, 2023 (CEST -Barcelona Time)
13:30-13:50 Title: Modelling thermal comfort of older people with dementia living in care homes: an evaluation of heat balance, adaptive comfort and thermographic methods
Choo-yoon Yi, The University of Sheffield, UK
13:50-14:10 Title: Transcriptomic Profiling reveals the key role of the HDAC1 gene in Frontotemporal Dementia
Amaan Arif, Amity University Uttar Pradesh, India
14:10-14:30 Title: Palliative care in advanced Alzheimer's disease dementia: evaluation of the answers given by caregivers to the accuracy of surprise question, as a prognostic tool.
Erika Kiyomi Yuyama ,Federal University of Uberlandia, Brazil
14:30-14:50 Title: Contributors to cognitive decline in adults
Graeme Peterson, Harvard University, USA
14:50-15:10 Title: Something New from Something Old:The Stages of Objective Memory Impairment (SOMI) System
Ellen Grober, Albert Einstein College of Medicine, USA
15:10-15:30 Title: Alzheimer’s Drugs: Beyond Antibodies 
Suren A.Tatulian, University of Central Florida, USA
15:30-15:50 Title: Natural α-galactoside- and β-glucoside-specific antibody immune complexes bound to surface O-glycoproteins of circulating platelets prevent aggregation, but dislodge at diabetic glucose levels
Karthi Sreedevi, Sree Chitra Tirunal Institute for medical sciences and technology, India
15:50-16:10 Title: Transcranial photobiomodulation to improve cognition and behavior/mood in ex-football players with possible chronic traumatic encephalopathy; improved functional connectivity and NAA levels on MRI
Margaret A. Naeser, Veterans Affairs Boston Healthcare System, Boston University School of Medicine, USA
16:10-16:30 Title: Synergistic influence of cytokine genes polymorphisms over the risk of dementia. A Multifactor Dimensionality Reduction Analysis.
Teresa Juarez-Cedillo,Mexican Social Security Institute, Mexico
16:30-17:00 Keynote: “Understanding & Curing Age-Related Neurologic Disease”
Michael Fossel,Telocyte LLC, USA
17:00-17:20 Title: DYRK1A-interacting proteins, a link between Down's syndrome and its comorbidities
Janel Nathalie,Paris City University, France
17:20-17:40 Title: What we know about recognizing older adults who are missing 
Vicki S.Gier, Mississippi State University-Meridian Campus, USA
17:40-18:00 Title: "Strategic Advance Care Planning”: a protocol that defines success as physicians/providers honoring patients’ wishes
Stanley A Terman, Caring Advocates, USA
18:00-18:20 Title: Federated Deep Learning for Detecting Alzheimer’s Disease in Multi-Cohort Brain MRI
Dimitris Stripelis, University of Southern California, USA
Day-2 Concludes

Download